QualityStocks would like to highlight ChromaDex (
OTCBB: CDXC), an innovative natural products company that discovers, acquires, develops, and commercializes proprietary-based ingredient technologies through its unique business model which utilizes its wholly-owned synergistic business units, including ingredient technologies, natural product fine chemicals (known as “phytochemicals”), chemistry and analytical testing services, and product regulatory and safety consulting (as Spherix Consulting).
In the company’s news,
ChromaDex has licensed from Green Molecular S.L. the exclusive worldwide patent rights pertaining to pharmaceutical and cosmetic preparations of pterostilbene for topical application for prevention and/or treatment of skin diseases, damage, or injuries, including those linked to aging and sun exposure.
Following this most recent acquisition, ChromaDex’ patent portfolio consists of eight patents and patents pending relating to pterostilbene. This is the company’s second acquisition made of worldwide patent rights for pTeroPure®, ChromaDex’s branded nature identical form of pterostilbene, associated with skincare.
“We intend to continue our strategy to build intellectual property around our ingredients. By building a robust skincare IP portfolio, we are positioning to become a meaningful provider of patent protected innovative ingredient technologies to this growing multi-billion dollar market place,” Frank Jaksch, founder and CEO of ChromaDex stated in the press release.
pTeroPure is an antioxidant found in blueberries. In September 2012, ChromaDex announced findings from a phase 2/3 trial demonstrating that pTeroPure significantly reduced blood pressure in adults. Along in addition to several other effects, pterostilbene has shown potential for supporting heart health, cognitive function, anti-aging, weight loss, and other metabolic disorders.
“I am excited to have this collaboration with ChromaDex. Pterostilbene, as well as its possible association with other structurally-related natural polyphenols, has multiple applications in,” Dr. Jose M. Estrela, research director of Green Molecular, stated. “Working with ChromaDex will allow for pterostilbene’s cosmetic and pharmaceutical applications in skin care and pathology to reach the market.”
About QualityStocks
QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.
To sign up for The QualityStocks Daily Newsletter, please visit
www.QualityStocks.com
To connect with QualityStocks via Facebook, please visit http://Facebook.com/QualityStocksPage
To connect with QualityStocks via Twitter, please visit http://Twitter.com/QualityStocks
Please read FULL disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com
Forward-Looking Statement:
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.
